Protective effects of hydralazine in a renal ischemia model in the rat

Life Sci. 1987 Aug 3;41(5):563-9. doi: 10.1016/0024-3205(87)90408-5.

Abstract

Renal ischemia was produced in anesthetized rats by a bilateral ligation of the renal artery, vein, and ureter. Pretreatment with hydralazine (0.3-10.0 mg/kg i.v.) resulted in a dose dependent reduction in elevated plasma creatinine levels 24 hr after a 60 min ischemic episode, indicating a protective effect on post-ischemic renal function. Hydralazine (3.0 mg/kg, i.v.) produced a fall in arterial blood pressure and exaggerated and/or extended post-ischemic depressions in renal blood flow, renal transport activity (in vitro para-aminohippurate uptake) and renal ATP levels. These results indicate that the hypotensive activity of hydralazine may have indirectly benefited the post-ischemic kidney by prolonging a relative anoxic condition which possibly allowed renal cells to recover under conditions where minimal tubular activity was present.

MeSH terms

  • Adenine Nucleotides / metabolism
  • Adenosine Triphosphate / metabolism
  • Animals
  • Biological Transport / drug effects
  • Blood Pressure / drug effects
  • Creatinine / blood
  • Hydralazine / pharmacology*
  • Hydralazine / therapeutic use
  • In Vitro Techniques
  • Ischemia / physiopathology
  • Ischemia / prevention & control*
  • Kidney Cortex / drug effects
  • Kidney Cortex / metabolism*
  • Male
  • Rats
  • Rats, Inbred Strains
  • Renal Circulation / drug effects*
  • p-Aminohippuric Acid / metabolism

Substances

  • Adenine Nucleotides
  • Hydralazine
  • Adenosine Triphosphate
  • Creatinine
  • p-Aminohippuric Acid